Literature DB >> 22291011

Insights into structural network responsible for oligomerization and activity of bacterial virulence regulator caseinolytic protease P (ClpP) protein.

Malte Gersch1, Anja List, Michael Groll, Stephan A Sieber.   

Abstract

The barrel-shaped caseinolytic protease P (ClpP) is a main virulence regulator in the bacterial pathogen Staphylococcus aureus (SaClpP). It consists of two heptameric rings forming a homotetradecamer with an inner chamber that houses the 14 active sites. We recently showed that SaClpP is able to adopt a compressed, inactive conformation. We present here the 2.3 Å resolution structure of SaClpP in its closed, active conformation as well as the structure of the S98A mutant. Comprehensive mutational analysis aiming at destabilizing one or the other or both conformations was able to pinpoint key residues involved in this catalytic switch and in the heptamer-heptamer interaction. By probing the active site serine with a covalently modifying β-lactone probe, we could show that the tetradecameric organization is essential for a proper formation of the active site. Structural data suggest that a highly conserved hydrogen-bonding network links oligomerization to activity. A comparison of ClpP structures from different organisms provides suggestive evidence for the presence of a universal mechanism regulating ClpP activity in which binding of one subunit to the corresponding subunit on the other ring interface is necessary for the functional assembly of the catalytic triad and thus for protease function. This mechanism ensures controlled access to the active sites of a highly unspecific protease.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22291011      PMCID: PMC3308785          DOI: 10.1074/jbc.M111.336222

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  34 in total

1.  Human mitochondrial ClpP is a stable heptamer that assembles into a tetradecamer in the presence of ClpX.

Authors:  Sung Gyun Kang; Mariana N Dimitrova; Joaquin Ortega; Ann Ginsburg; Michael R Maurizi
Journal:  J Biol Chem       Date:  2005-08-22       Impact factor: 5.157

2.  Dysregulation of bacterial proteolytic machinery by a new class of antibiotics.

Authors:  Heike Brötz-Oesterhelt; Dieter Beyer; Hein-Peter Kroll; Rainer Endermann; Christoph Ladel; Werner Schroeder; Berthold Hinzen; Siegfried Raddatz; Holger Paulsen; Kerstin Henninger; Julia E Bandow; Hans-Georg Sahl; Harald Labischinski
Journal:  Nat Med       Date:  2005-10-02       Impact factor: 53.440

3.  Global virulence regulation in Staphylococcus aureus: pinpointing the roles of ClpP and ClpX in the sar/agr regulatory network.

Authors:  Dorte Frees; Karen Sørensen; Hanne Ingmer
Journal:  Infect Immun       Date:  2005-12       Impact factor: 3.441

Review 4.  ClpXP, an ATP-powered unfolding and protein-degradation machine.

Authors:  Tania A Baker; Robert T Sauer
Journal:  Biochim Biophys Acta       Date:  2011-06-27

5.  Global regulatory impact of ClpP protease of Staphylococcus aureus on regulons involved in virulence, oxidative stress response, autolysis, and DNA repair.

Authors:  Antje Michel; Franziska Agerer; Christof R Hauck; Mathias Herrmann; Joachim Ullrich; Jörg Hacker; Knut Ohlsen
Journal:  J Bacteriol       Date:  2006-08       Impact factor: 3.490

6.  A cyanobacterial serine protease of Plasmodium falciparum is targeted to the apicoplast and plays an important role in its growth and development.

Authors:  Sumit Rathore; Dipto Sinha; Mohd Asad; Thomas Böttcher; Farhat Afrin; Virander S Chauhan; Dinesh Gupta; Stephan A Sieber; Asif Mohmmed
Journal:  Mol Microbiol       Date:  2010-06-10       Impact factor: 3.501

7.  Structures of ClpP in complex with acyldepsipeptide antibiotics reveal its activation mechanism.

Authors:  Byung-Gil Lee; Eun Young Park; Kyung-Eun Lee; Hyesung Jeon; Kwang Hoon Sung; Holger Paulsen; Helga Rübsamen-Schaeff; Heike Brötz-Oesterhelt; Hyun Kyu Song
Journal:  Nat Struct Mol Biol       Date:  2010-03-21       Impact factor: 15.369

8.  A multiple-component, ATP-dependent protease from Escherichia coli.

Authors:  Y Katayama-Fujimura; S Gottesman; M R Maurizi
Journal:  J Biol Chem       Date:  1987-04-05       Impact factor: 5.157

9.  Beta-lactones as specific inhibitors of ClpP attenuate the production of extracellular virulence factors of Staphylococcus aureus.

Authors:  Thomas Böttcher; Stephan A Sieber
Journal:  J Am Chem Soc       Date:  2008-10-11       Impact factor: 15.419

10.  ClpA and ClpX ATPases bind simultaneously to opposite ends of ClpP peptidase to form active hybrid complexes.

Authors:  Joaquin Ortega; Hyun Sook Lee; Michael R Maurizi; Alasdair C Steven
Journal:  J Struct Biol       Date:  2004 Apr-May       Impact factor: 2.867

View more
  24 in total

Review 1.  Bacterial proteases, untapped antimicrobial drug targets.

Authors:  Elizabeth Culp; Gerard D Wright
Journal:  J Antibiot (Tokyo)       Date:  2016-11-30       Impact factor: 2.649

2.  Reversible inhibition of the ClpP protease via an N-terminal conformational switch.

Authors:  Siavash Vahidi; Zev A Ripstein; Massimiliano Bonomi; Tairan Yuwen; Mark F Mabanglo; Jordan B Juravsky; Kamran Rizzolo; Algirdas Velyvis; Walid A Houry; Michele Vendruscolo; John L Rubinstein; Lewis E Kay
Journal:  Proc Natl Acad Sci U S A       Date:  2018-06-25       Impact factor: 11.205

3.  Suppression of Staphylococcus aureus virulence by a small-molecule compound.

Authors:  Peng Gao; Pak Leung Ho; Bingpeng Yan; Kong Hung Sze; Julian Davies; Richard Yi Tsun Kao
Journal:  Proc Natl Acad Sci U S A       Date:  2018-07-16       Impact factor: 11.205

4.  Perrault syndrome is caused by recessive mutations in CLPP, encoding a mitochondrial ATP-dependent chambered protease.

Authors:  Emma M Jenkinson; Atteeq U Rehman; Tom Walsh; Jill Clayton-Smith; Kwanghyuk Lee; Robert J Morell; Meghan C Drummond; Shaheen N Khan; Muhammad Asif Naeem; Bushra Rauf; Neil Billington; Julie M Schultz; Jill E Urquhart; Ming K Lee; Andrew Berry; Neil A Hanley; Sarju Mehta; Deirdre Cilliers; Peter E Clayton; Helen Kingston; Miriam J Smith; Thomas T Warner; Graeme C Black; Dorothy Trump; Julian R E Davis; Wasim Ahmad; Suzanne M Leal; Sheikh Riazuddin; Mary-Claire King; Thomas B Friedman; William G Newman
Journal:  Am J Hum Genet       Date:  2013-03-28       Impact factor: 11.025

5.  Helix unfolding/refolding characterizes the functional dynamics of Staphylococcus aureus Clp protease.

Authors:  Fei Ye; Jie Zhang; Hongchuan Liu; Rolf Hilgenfeld; Ruihan Zhang; Xiangqian Kong; Lianchun Li; Junyan Lu; Xinlei Zhang; Donghai Li; Hualiang Jiang; Cai-Guang Yang; Cheng Luo
Journal:  J Biol Chem       Date:  2013-04-26       Impact factor: 5.157

6.  EMBO conference series: Chemical Biology 2014.

Authors:  Eileen J Kennedy
Journal:  Chembiochem       Date:  2014-10-16       Impact factor: 3.164

7.  Clostridium difficile ClpP Homologues are Capable of Uncoupled Activity and Exhibit Different Levels of Susceptibility to Acyldepsipeptide Modulation.

Authors:  Nathan P Lavey; Tyler Shadid; Jimmy D Ballard; Adam S Duerfeldt
Journal:  ACS Infect Dis       Date:  2018-11-26       Impact factor: 5.084

8.  Structural and functional insights into caseinolytic proteases reveal an unprecedented regulation principle of their catalytic triad.

Authors:  Evelyn Zeiler; Anja List; Ferdinand Alte; Malte Gersch; Rudolf Wachtel; Marcin Poreba; Marcin Drag; Michael Groll; Stephan A Sieber
Journal:  Proc Natl Acad Sci U S A       Date:  2013-06-24       Impact factor: 11.205

9.  Structure and Functional Properties of the Active Form of the Proteolytic Complex, ClpP1P2, from Mycobacterium tuberculosis.

Authors:  Mi Li; Olga Kandror; Tatos Akopian; Poorva Dharkar; Alexander Wlodawer; Michael R Maurizi; Alfred L Goldberg
Journal:  J Biol Chem       Date:  2016-02-08       Impact factor: 5.157

10.  An allosteric switch regulates Mycobacterium tuberculosis ClpP1P2 protease function as established by cryo-EM and methyl-TROSY NMR.

Authors:  Siavash Vahidi; Zev A Ripstein; Jordan B Juravsky; Enrico Rennella; Alfred L Goldberg; Anthony K Mittermaier; John L Rubinstein; Lewis E Kay
Journal:  Proc Natl Acad Sci U S A       Date:  2020-03-02       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.